...
首页> 外文期刊>Oncogene >Interaction of AF4 wild-type and AF4|[middot]|MLL fusion protein with SIAH proteins: indication for t(4;11) pathobiology?
【24h】

Interaction of AF4 wild-type and AF4|[middot]|MLL fusion protein with SIAH proteins: indication for t(4;11) pathobiology?

机译:AF4野生型和AF4 | mid | MLL融合蛋白与SIAH蛋白的相互作用:指示t(4; 11)病理生物学?

获取原文
           

摘要

The human AF4 (ALL-1 fused gene on chromosome 4) gene (4q11) is recurrently involved in reciprocal translocations to the MLL (mixed lineage leukemia) gene (11q23), correlated with high-risk acute lymphoblastic leukemia (ALL) in infants and early childhood. The t(4;11) translocation is one of the most frequent MLL translocations known today. In general, MLL translocations are the result of an illegitimate recombination process leading to reciprocal fusions of unrelated translocation partner (TP) genes with the MLL gene. Owing to the constant presence of the derivative (11) product, it was hypothesised that only MLLTP fusion genes are responsible for the leukemogenic process. This concept has been successfully tested for some known MLL fusions, while other MLL fusions failed. Here, we demonstrate growth-transforming potential of AF4 wild-type and the AF4MLL fusion protein. The underlying oncogenic mechanism involves the two E3 ubiquitin ligases SIAH1 and SIAH2, the N-terminal portion of AF4 and the protection of the AF4MLL fusion protein against proteosomal degradation.
机译:人类AF4(4号染色体上的ALL-1融合基因)基因(4q11)反复参与向MLL(混合谱系白血病)基因(11q23)的相互易位,与婴儿和婴儿的高危急性淋巴细胞白血病(ALL)相关孩提时代。 t(4; 11)易位是当今已知的最频繁的MLL易位之一。通常,MLL易位是非法重组过程的结果,该重组过程导致无关的易位伴侣(TP)基因与MLL基因相互融合。由于衍生物(11)产物的持续存在,据推测只有MLLTP融合基因才是致白血病的过程。此概念已针对某些已知的MLL融合成功进行了测试,而其他MLL融合则失败了。在这里,我们证明了AF4野生型和AF4MLL融合蛋白的生长转化潜力。潜在的致癌机制涉及两个E3泛素连接酶SIAH1和SIAH2,AF4的N端部分以及AF4MLL融合蛋白针对蛋白质体降解的保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号